Adventris Pharmaceuticals
Adventris makes cancer vaccines
About
Adventris makes cancer vaccines. Our platform solves the problem of targeting poorly immunogenic oncogenes. Our first "off-the-shelf" vaccine targets KRAS, the most common cancer oncogene. In the long run, we envision a world where every adult receives our pan-cancer vaccines annually – preventing the majority of cancer deaths.
If you are interested in learning more about our approach to treat and prevent cancer, please reach out to us at [email protected]
Topics
- Location
- Baltimore, MD, United States
- Team size
- 7 employees
- YC batch
- Winter 2023
- Status
- Active
- Stage
- Early stage
